CTOs on the Move

Transcend Health

www.transcend.healthcare

 
Transcend Health is a healthcare company that provides a digital health platform for first responders, encompassing health, physical fitness, training, and wellness. They also offer a Direct Primary Care model for employers to provide superior access t...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

EsferaMed International

EsferaMed International is a Scottsdale, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mannatech

Mannatech, Incorporated is a global wellness solution provider. The Company develops and sells a range of nutritional supplements, topical and skin care products, and weight-management products that target optimal health and wellness.

Oklahoma Methodist Manor

Oklahoma Methodist Manor is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Oklahoma Methodist Manor is based in Tulsa, OK. You can find more information on Oklahoma Methodist Manor at www.ommtulsa.org

Ample Scientific

Ample Scientific is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.